Financials
- Market Capitalization 2.41 B
- Employee 100
- Founded 2019
- CEO N/A
- Website www.newamsterdampharma.com
- Headquarter Netherlands
- FIGI N/A
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-20.4
市销率
184.61
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1797 | SLS SELLAS Life Sciences Group, Inc. - Common Stock | 12.41 USD | +4.02% | +10.21% | +13.75% | +514.36% | 2.51 B USD | ||
| 1817 | NRIX Nurix Therapeutics, Inc. - Common stock | 22.13 USD | -0.14% | -1.34% | -11.52% | +97.41% | 2.42 B USD | ||
| 1825 | LQDA Liquidia Corporation - Common Stock | 26.81 USD | -3.11% | +4.69% | -59.86% | +18.63% | 2.40 B USD | ||
| 1848 | ADMA ADMA Biologics Inc - Common Stock | 10.31 USD | +1.28% | +1.58% | +10.50% | -29.14% | 2.31 B USD |